Login / Signup

In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease.

Rania AlaaeldinMuhamad MustafaGamal El-Din A Abuo-RahmaMoustafa Fathy
Published in: Fundamental & clinical pharmacology (2021)
The new chalcone might be useful and has new insights for the inhibition of SARS-CoV-2 Mpro .
Keyphrases
  • sars cov
  • molecular docking
  • respiratory syndrome coronavirus
  • molecular dynamics simulations
  • pseudomonas aeruginosa
  • coronavirus disease